The demand for craniomaxillofacial devices is anticipated to grow in the future with the rising number of cosmetic and reconstructive procedures. While cosmetic procedures are carried out to improve overall cosmetic appearance by reshaping and altering natural anatomy to make it visually more appealing, reconstructive surgeries are carried out to address deformities induced by birth abnormalities, trauma, or medical diseases including cancer. By reshaping and modifying normal anatomy to make it more aesthetically pleasing, CMF devices are utilized to improve overall cosmetic attractiveness. For instance, the Aesthetic Society, a US-based authority on aesthetic plastic surgery, issued the 2020–2021 Aesthetic Plastic Surgery Statistics, which show that generally, aesthetic body operations like liposuction, buttock augmentation, and abdominoplasty grew by 63% since 2020 in 2021. In 2021, the mean plastic surgeon executed 320 surgical procedures, as opposed to 220 in 2020. Therefore, the rising need for reconstructive and cosmetic procedures is boosting the craniomaxillofacial devices market size.
The craniomaxillofacial devices market has been segmented on the basis of product, material, and application. By product, the market is divided craniomaxillofacial plate and screw fixation, cranial flap fixation, Craniomaxillofacial distraction, temporomandibular joint replacement, thoracic fixation, and bone graft substitute. Based on material, the market is segmented into depth of metal bio absorbable material, and ceramics. In terms of application, the market is segmented into neurosurgery and ENT, orthognathic and dental surgery, and plastic surgery. The scope of the craniomaxillofacial devices market report includes North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).
North America held the largest share of the craniomaxillofacial devices market in 2023, and it is projected to maintain its dominance (in terms of share) during the forecast period. The US holds the largest share of the market in North America and the world. Rise in sports and facial fractures as well as the national presence of all international athletes is driving the market growth in US. The demand for minimally invasive operations is rising, and advances in technology in the field of craniomaxillofacial fixation are contributing to this rise in the investigated region.
The craniomaxillofacial devices market analysis is carried out by identifying and evaluating key players in the market across different regions.
Craniomaxillofacial Devices Market: Competitive Landscape and Key Developments
DePuy Synthes (J&J), Stryker, Medtronic, B. Braun Melsungen AG, Reni Shaw plc., Medartis AG, KLS Martin Group, Xilloc Medical B. V, Synimed, and Zimmer-Biomet are a few key companies operating in the craniomaxillofacial devices market. Market players adopt product innovation strategies to meet evolving customer demands, maintaining their brand image in the craniomaxillofacial devices market.